• Recent news

  • ArcticZymes signs new supply agreement for enzyme, Cod UNG

    (Tromsø 13. December 2018) Biotec Pharmacon’s (OSE: Biotec) subsidiary ArcticZymes has signed a supply agreement with a major Japanese company for its product Cod UNG. ArcticZymes AS, a leader in the development and commercialization of enzymes applied to molecular diagnostics, gene therapy, and protein purification, announces a new dual track supply agreement…

    Continue reading

Latest presentation

Third quarter 2018 results

Loading video...

(Tromsø, October 18, 2018) Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 22.1 million (14.4) in the third quarter of 2018, and a negative EBITDA of NOK 0.2 million (-7.3). ArcticZymes generated sales of NOK 9.8 million during the third quarter whereas Woulgan® generated sales of NOK 0.9 million.  “At…

View more